Biggest News Aggregation in the World
📰 Human Use News

Page 140 - Human Use News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.

Menarini Industrie Farmaceutiche Riunite: Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma

-- European Commission Decision Anticipated within Approximately 60 Days -- NEWTON, Mass. and FLORENCE, Italy, May 20, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI),
United States United Kingdom Northern Ireland Richard Paulson Elcin Barker Ergun Selective Inhibitor Of Nuclear Export

Merck & Co., Inc.: Merck Receives Positive EU CHMP Opinion for KEYTRUDA (pembrolizumab) as Adjuvant Treatment for Adult and Adolescent (=12 Years of Age) Patients With Stage IIB or IIC Melanoma Following Complete Resection

Opinion granted based on positive results from the Phase 3 KEYNOTE-716 trial If approved, KEYTRUDA would be the first anti-PD-1 immunotherapy treatment option for patients 12 years and older in
United States Scot Ebbinghaus Peter Dannenbaum Damini Chokshi Melissa Moody Merck Research Laboratories

ClearPoint Neuro Congratulates Partner PTC Therapeutics on Receiving Positive CHMP Opinion for Gene Therapy to Treat AADC Deficiency

SOLANA BEACH, Calif., May 20, 2022 -- ClearPoint Neuro, Inc. , a global therapy-enabling platform company providing navigation and delivery to the brain, today congratulates partner PTC... | May 20, 2022
United States Joe Burnett Jacqueline Keller Company Clearpoint Neuro Navigation System Clearpoint Neuro Inc Exchange Commission

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science